Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aleeto transdermal microneedle for idiopathic facial paralysis (recovery phase)
ChiCTR2500099150Phase 2Not yet recruiting
- Sponsor
- Tsinghua University Yuquan Hospital
- Start
- Mar 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label trial of aleeto protein in Bell's palsy (2 arms), sponsored by Tsinghua University Yuquan Hospital. Primary endpoints: House-Brackmann scale, Sunnybrook scale and 5 more. Planned start Mar 2025; status: not yet recruiting.
02
Drugs
aleeto protein
03
Conditions
Bell's palsy
Beyond the preview
Go deeper on ChiCTR2500099150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500099150.